LivaNova PLC (NasdaqGS:LIVN) entered into an agreement to acquire the remaining stake in ImThera Medical, Inc. from Spencer Trask & Company for approximately $230 million on December 5, 2017. Under the terms of agreement, LivaNova will pay $78 million upfront in cash and the remaining portion of approximately $150 million will paid on a schedule driven by regulatory and sales milestones. The transaction is subject to approvals and other customary closing conditions. The transaction is expected to close in early 2018 and is projected to be near-term accretive. LivaNova PLC (NasdaqGS:LIVN) completed the acquisition of the remaining stake in ImThera Medical, Inc. from Spencer Trask & Company on January 16, 2018.